Picture of BACHEM HOLDING AG logo

BANB — BACHEM HOLDING AG News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapHigh Flyer

Switzerland's Bachem 2025 sales beat on strong product demand

Overview

Switzerland peptide maker's 2025 sales rose 14.8%, beating analyst expectations

EBITDA margin reached 30.9%, with adjusted margin at 28.6% after one-time effects

Company expects 2026 sales growth of 35-45% in local currencies

Outlook

Bachem expects 2026 sales growth of 35%-45% in local currencies

Company sees 2026 EBITDA margin in the low thirties in local currencies

Bachem plans CAPEX investments of more than CHF 400 mln in 2026

Result Drivers

STRONG PRODUCT DEMAND - Co said demand for its products and services remained strong, with a high order situation

PATENT-PROTECTED PEPTIDES - Sales growth in commercial active ingredients was mainly due to higher sales of patent-protected peptides

OPERATIONAL IMPROVEMENTS - Targeted operational improvements increased facility capacity and improved cost structure

Company press release: ID:nNFC2hfJ8h

Key Details

MetricBeat/MissActualConsensus Estimate
FY SalesBeatCHF 695.10 mlnCHF 686.81 mln (9 Analysts)
FY Net IncomeCHF 148.80 mln
FY EBITCHF 167.30 mln
FY EBITDACHF 214.70 mln
FY EBITDA Margin30.90%
FY EBIT Margin24.10%
Analyst Coverage The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 5 "strong buy" or "buy", 3 "hold" and 1 "sell" or "strong sell" The average consensus recommendation for the biotechnology & medical research peer group is "buy." Wall Street's median 12-month price target for BACHEM HOLDING AG is CHF76.50, about 39.2% above its March 11 closing price of CHF54.95 The stock recently traded at 24 times the next 12-month earnings vs. a P/E of 23 three months ago For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on BACHEM HOLDING AG

See all news